Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Phase 3 Study Efficacy and Tolerance: The Use of 2 Phytomedicines in Association GAMALINE® 900mg + HIPERICIN® 300mg for the Treatment of Pre-Menstrual Syndrome (PMS) and Vasomotor Symptoms

NCT01365676 is registered in ClinicalTrials.gov with Phytopharm Consulting Brazil as lead sponsor.

NCT NCT01365676
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01365676 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Phase 3 Study Efficacy and Tolerance: The Use of 2 Phytomedicines in Association GAMALINE® 900mg + HIPERICIN® 300mg for the Treatment of Pre-Menstrual Syndrome (PMS) and Vasomotor Symptoms
Lead sponsor
Phytopharm Consulting Brazil
Phase
Phase 3
Overall status
Unknown status
Start date
March 31, 2012
Completion date
December 31, 2012
Enrollment
240 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

premenstrual syndrome, uterus; hemorrhage, preclimacteric or premenopausal